Compare stocks

Demant A/S is a company specializing in hearing healthcare solutions. It operates in the medical technology industry, providing hearing aids, audiometric equipment, and hearing implants. The company also offers personal communication solutions and hearing care services through its retail network. Founded in 1904 and headquartered in Smørum, Denmark, Demant has a significant presence in Europe, North America, and other regions, serving users worldwide. The company's strategic positioning is strengthened by its focus on R&D and innovation, which supports its diverse product portfolio and ability to meet various customer needs in the hearing health market.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio, while the 2026 acquisition of Apogee adds to AbbVie's immunology depth.